Evidence map›Paper›PMID 29042909›Full record

ArticleExperimental and therapeutic medicine2017

Elevation of

Qing Huang, Liyuan Han, Yanfen Liu, Changyi Wang, Donghui Duan, Nanjia Lu, Kaiyue Wang, Lu Zhang, Kaibo Gu, Shiwei Duan and 1 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental and therapeutic medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Qing HuangThe Affiliated Hospital of Ningbo University School of Medicine, Ningbo, Zhejiang 315020, P.R. China.
Liyuan HanGenetics Center, School of Medicine, Ningbo University, Ningbo, Zhejiang 315211, P.R. China.
Yanfen LiuGenetics Center, School of Medicine, Ningbo University, Ningbo, Zhejiang 315211, P.R. China.
Changyi WangDepartment of Chronic Disease Prevention and Control, Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen, Guangdong 518000, P.R. China.
Donghui DuanGenetics Center, School of Medicine, Ningbo University, Ningbo, Zhejiang 315211, P.R. China.
Nanjia LuGenetics Center, School of Medicine, Ningbo University, Ningbo, Zhejiang 315211, P.R. China.
Kaiyue WangGenetics Center, School of Medicine, Ningbo University, Ningbo, Zhejiang 315211, P.R. China.
Lu ZhangGenetics Center, School of Medicine, Ningbo University, Ningbo, Zhejiang 315211, P.R. China.
Kaibo GuGenetics Center, School of Medicine, Ningbo University, Ningbo, Zhejiang 315211, P.R. China.
Shiwei DuanGenetics Center, School of Medicine, Ningbo University, Ningbo, Zhejiang 315211, P.R. China.
Yifeng MaiThe Affiliated Hospital of Ningbo University School of Medicine, Ningbo, Zhejiang 315020, P.R. China.
Ningbo University · CNNingbo University Affiliated Hospital · CNShenzhen Nanshan Center for Chronic Disease Control · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aimed to investigate the contribution of DNA methylation of the protein tyrosine phosphatase, non-receptor type 1 (

Indexed as

methylationnon-receptor type 1promoterprotein tyrosine phosphatasetype 2 diabetes

Identifiers

PMID29042909
PMCPMC5639402
OpenAlexW2744797622

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.